Guardant Health, Inc. (GH) 追踪市盈率为负值 -27.6, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 80.1 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -3.62%, 前瞻盈利收益率 1.25%. PEG 0.65 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 57/100 其中 4/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -9.2 | 0.00 | 5.34 | 16.86 | - |
| 2017 | -27.4 | 0.41 | 7.38 | 45.69 | - |
| 2018 | -37.6 | 2.46 | 6.62 | 35.26 | - |
| 2019 | -93.6 | 3.74 | 8.87 | 33.02 | - |
| 2020 | -49.5 | -0.21 | 9.68 | 43.83 | - |
| 2021 | -25.0 | -0.50 | 15.71 | 27.12 | - |
| 2022 | -4.2 | -0.06 | 46.18 | 6.18 | - |
| 2023 | -6.3 | 0.19 | 19.09 | 5.37 | - |
| 2024 | -8.6 | 0.51 | -26.85 | 5.07 | - |
| 2025 | -30.8 | 4.56 | -128.95 | 13.04 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.65 | $25.25M | $-46.14M | -182.7% |
| 2017 | $-1.18 | $49.84M | $-83.22M | -167% |
| 2018 | $-2.80 | $90.64M | $-85.06M | -93.8% |
| 2019 | $-0.75 | $214.38M | $-67.85M | -31.7% |
| 2020 | $-2.53 | $286.73M | $-246.28M | -85.9% |
| 2021 | $-3.80 | $373.65M | $-384.77M | -103% |
| 2022 | $-6.41 | $449.54M | $-654.59M | -145.6% |
| 2023 | $-4.28 | $563.95M | $-479.45M | -85% |
| 2024 | $-3.56 | $739.02M | $-436.37M | -59% |
| 2025 | $-3.32 | $982.02M | $-416.28M | -42.4% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-2.95 | $-3.50 – $-2.74 | $1.27B | $1.26B – $1.34B | 12 |
| 2027 | $-1.93 | $-2.73 – $-0.87 | $1.63B | $1.6B – $1.72B | 12 |
| 2028 | $-0.13 | $-0.51 – $0.42 | $2.05B | $2.04B – $2.06B | 8 |
| 2029 | $1.04 | $1.01 – $1.11 | $2.48B | $2.43B – $2.62B | 6 |
| 2030 | $2.36 | $2.30 – $2.52 | $3.05B | $2.99B – $3.22B | 6 |
